Argentine Energy Firm PCR Raises $400M in Bond Debut

By The Rio Times | Created at 2026-07-26 07:15:17 | Updated at 2026-08-08 13:00:37 1 week ago

Daily Brief

The morning intel from across Latin America. Free.

By subscribing you agree to our privacy policy. We never share your email.

Company News · Argentina

Key Facts

The debut. Petroquímica Comodoro Rivadavia (PCR), with its subsidiary Luz de Tres Picos, placed its first international bond.

The size. The Class I notes raised US$400 million, up from an initial target of US$350 million after strong demand.

The terms. The dollar notes were issued under New York law with an eight-year maturity and a fixed 8.5% annual coupon.

The demand. Orders reached close to US$1 billion, about 2.5 times the amount awarded, led by US and European institutions.

The use. Proceeds will repay financial debt at PCR and Luz de Tres Picos and fund energy investment projects.

Argentine energy company PCR has raised US$400 million in its first-ever international bond, drawing roughly US$1 billion in orders in a sign that global investors are warming again to Argentine corporate credit.

Argentine energy sectorPCR operates across oil, gas and renewable energy in Argentina. (Photo: Wikimedia Commons)

One-stop reference

Company Intelligence

Every listed company in Latin America — financials, ownership and structure for 1,450+ companies across 26 exchanges, in one place.

Browse the directory →

A First Step Into Global Markets

PCR, a Comodoro Rivadavia-based energy group active in oil, gas and wind, had never tapped international bond markets before. Its debut US$400 million placement marks a milestone for the company and a test of appetite for Argentine corporate risk.

Issued alongside its subsidiary Luz de Tres Picos, the deal was structured under New York law. That framework gives foreign investors the legal comfort they typically require.

Strong Demand Drives an Upsize

The company initially sought up to US$350 million but lifted the size to US$400 million as orders poured in. Demand reached close to US$1 billion, roughly two and a half times the final amount.

Buyers spanned institutional investors in the United States and Europe, alongside local support. The eight-year notes priced at a fixed 8.5% annual coupon.

What the Money Is For

PCR said the proceeds will refinance existing debt at both PCR and Luz de Tres Picos. The rest will fund investment projects across its energy portfolio.

Refinancing at a fixed long-term rate lets the company lock in costs and extend maturities. For a capital-intensive energy business, that stability matters.

The Argentine Read-Through

A heavily subscribed debut from an Argentine issuer signals thawing investor sentiment toward the country’s corporates. It follows a broader reopening of external financing for select Argentine names.

For investors, PCR’s 8.5% coupon captures both the opportunity and the risk premium still attached to Argentina. For the energy sector, it is fresh capital to fund growth as the country leans on Vaca Muerta and renewables.

Frequently Asked Questions

How much did PCR raise in its first international bond?

PCR raised US$400 million, up from an initial target of US$350 million, in its debut international bond issued with subsidiary Luz de Tres Picos.

What are the terms of the PCR bond?

The dollar notes were issued under New York law with an eight-year maturity and a fixed 8.5% annual coupon, drawing orders of close to US$1 billion.

What will PCR use the funds for?

The company will use the proceeds to refinance debt at PCR and Luz de Tres Picos and to fund investment projects in its energy business.

Sources

The Rio Times · Power Map

See who really holds power in Latin America

Click to open the Power Map

Read Entire Article